These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 15945000

  • 1. Cataract surgery combined with intravitreal injection of triamcinolone acetonide.
    Jonas JB, Kreissig I, Budde WM, Degenring RF.
    Eur J Ophthalmol; 2005; 15(3):329-35. PubMed ID: 15945000
    [Abstract] [Full Text] [Related]

  • 2. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB, Kreissig I, Kamppeter B, Degenring RF.
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB.
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [Abstract] [Full Text] [Related]

  • 4. Cataract surgery after intravitreal injection of triamcinolone acetonide.
    Jonas JB, Kreissig I, Degenring RF.
    Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC, Wu WC, Chen KJ.
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X, Li J, Hu X, Yu S, Pan J, Tang S.
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB, Kreissig I, Degenring RF.
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion.
    Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF.
    Eur J Ophthalmol; 2005 Jun; 15(6):751-8. PubMed ID: 16329061
    [Abstract] [Full Text] [Related]

  • 9. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A, Kowalska K, Jankowska-Lech I, Terelak-Borys B, Nowosielska A, Grabska-Liberek I.
    Klin Oczna; 2011 Jun; 113(4-6):127-31. PubMed ID: 21913440
    [Abstract] [Full Text] [Related]

  • 10. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.
    Tewari HK, Sony P, Chawla R, Garg SP, Venkatesh P.
    Eur J Ophthalmol; 2005 Jun; 15(5):619-26. PubMed ID: 16167293
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal triamcinolone acetonide for diabetic macular edema.
    Chieh JJ, Roth DB, Liu M, Belmont J, Nelson M, Regillo C, Martidis A.
    Retina; 2005 Jun; 25(7):828-34. PubMed ID: 16205559
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ, Zaheer I, Karia N.
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB.
    Ophthalmic Res; 2006 Jan; 38(4):218-45. PubMed ID: 16763379
    [Abstract] [Full Text] [Related]

  • 14. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA, Melo LA, Costa RA, Skaf M, Belfort R, Souza-Filho AA, Farah ME, Kuppermann BD.
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE, Puliafito CA.
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
    Cekiç O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM.
    Retina; 2005 Aug; 25(7):846-50. PubMed ID: 16205562
    [Abstract] [Full Text] [Related]

  • 17. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide.
    Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF.
    Eye (Lond); 2005 Jan; 19(1):65-71. PubMed ID: 15105817
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
    Tao Y, Hou J, Jiang YR, Li XX, Jonas JB.
    Eye (Lond); 2010 May; 24(5):810-5. PubMed ID: 19696805
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
    Jonas JB, Kreissig I, Degenring R.
    Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion.
    Ozkiris A, Evereklioglu C, Erkiliç K, Ilhan O.
    Eur J Ophthalmol; 2005 Sep; 15(1):96-101. PubMed ID: 15751246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.